Adcock Ingram The mysterious East
An interesting bit of news that somehow never made it onto our radar: Adcock Ingram, SA’s second-largest pharmaceutical manufacturer, has opened its first factory in Bengaluru, India, a three-floor, 7,878sqm plant with an annual production capacity of 750 million tablets, 75 million sachets, and four million bottles. The factory, which it has opened with its Indian partner Medreich Ltd. under the Adcock Ingram Pharma banner, will allow it to expand production capacity for its contract manufacturing organization (CMO) business. This means, as far as we can tell, that Adcock Ingram Pharma will sell meds to Adcock Ingram Holdings back in SA, and to other clients under their own brands. Medreich operates in 55 countries and manufactures medications for GSK, Pfizer, Sanofi Aventis, Novartis, Mylan, Apotex, and of course Adcock Ingram, inter alia. It is itself part of the Meiji Group, a leading Japanese conglomerate with interests across the globe in pharmaceuticals, food and nutrition products.
Comment: A rabbit hole of ownerships, partnership, joint ventures and licensing agreements in this most ingewikkeld of industries.